Grutters JC, van den Borsch JMM. Connective Tissue Disorders. Clinical Respiratory Medicine. Third ed2008. p. 713\u201327.<\/p>\n
Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2005;17(6):701\u20136.<\/p>\n
Article<\/a>\u00a0 Steen VD. The lung in systemic sclerosis. J Clin Rheumatol. 2005;11(1):40\u20136.<\/p>\n Article<\/a>\u00a0 Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372\u20138.<\/p>\n Article<\/a>\u00a0 Olson AL, Brown KK, Fischer A. Connective tissue disease-associated lung disease. Immunol Allergy Clin North Am. 2012;32(4):513\u201336.<\/p>\n Article<\/a>\u00a0 Karimi-Shah BA, Chowdhury BA. Forced vital capacity in idiopathic pulmonary fibrosis\u2013FDA review of pirfenidone and nintedanib. N Engl J Med. 2015;372(13):1189\u201391.<\/p>\n Article<\/a>\u00a0 Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.<\/p>\n Article<\/a>\u00a0 Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med. 2016;194(3):265\u201375.<\/p>\n Article<\/a>\u00a0 Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37(2):356\u201363.<\/p>\n Article<\/a>\u00a0 Suzuki A, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, et al. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: a retrospective cohort study. Clin Respir J. 2018;12(3):895\u2013903.<\/p>\n Article<\/a>\u00a0 Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, et al. Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2016;194(8):989\u201397.<\/p>\n Article<\/a>\u00a0 Khan F, Howard L, Hearson G, Edwards C, Barber C, Jones S, et al. Clinical utility of home versus hospital spirometry in fibrotic interstitial lung disease: evaluation after INJUSTIS interim analysis. Ann Am Thorac Soc. 2022;19(3):506\u20139.<\/p>\n Article<\/a>\u00a0 Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts J, Chavannes NH, et al. Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial. Am J Respir Crit Care Med. 2020;202(3):393\u2013401.<\/p>\n Article<\/a>\u00a0 Khor YH, Gutman L, Abu Hussein N, Johannson KA, Glaspole IN, Guler SA, et al. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study. Chest. 2021;160(3):994\u20131005.<\/p>\n Article<\/a>\u00a0 Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, et al. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.01518-2020<\/a>.<\/p>\n Article<\/a>\u00a0 Barth S, Edwards C, Saini G, Haider Y, Williams NP, Storrar W, et al. Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study. Respir Res. 2024;25(1):162.<\/p>\n Article<\/a>\u00a0 Velauthapillai A, Moor CC, de Vries-Bouwstra JK, Wijsenbeek-Lourens MS, van den Ende CHM, Vonk MC. Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study. Lancet Rheumatol. 2025;7(3):e178\u201386.<\/p>\n Article<\/a>\u00a0 Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.<\/p>\n Article<\/a>\u00a0 van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.<\/p>\n Article<\/a>\u00a0 Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35\u201345.<\/p>\n Article<\/a>\u00a0 Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364.<\/p>\n Article<\/a>\u00a0 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.<\/p>\n Article<\/a>\u00a0 Alarc\u00f3n-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. Amsterdam: Elsevier; 1987.<\/p>\n Papiris SA, Daniil ZD, Malagari K, Kapotsis GE, Sotiropoulou C, Milic-Emili J, et al. The medical research council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med. 2005;99(6):755\u201361.<\/p>\n Article<\/a>\u00a0 Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339\u201343.<\/p>\n Article<\/a>\u00a0 Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King\u2019s brief interstitial lung disease (K-BILD) health status questionnaire. Thorax. 2012;67(9):804\u201310.<\/p>\n Article<\/a>\u00a0 Tsai APY, Hur SA, Wong A, Safavi M, Assayag D, Johannson KA, et al. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax. 2021;76(1):37\u201343.<\/p>\n Article<\/a>\u00a0 Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145(4):723\u20138.<\/p>\n Article<\/a>\u00a0 Nakshbandi G, Moor C., Aerts J., Wijsenbeek M. eHealth in pulmonary fibrosis: An international survey among healthcare providers and patients. European Respiratory Journal. 2020;56.<\/p>\n De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323.<\/p>\n Article<\/a>\u00a0 Breekveldt-Postma NS, Koerselman J, Erkens JA, van der Molen T, Lammers JW, Herings RM, et al. Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf. 2008;17(4):411\u201322.<\/p>\n Article<\/a>\u00a0 Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.<\/p>\n Article<\/a>\u00a0 Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 2000;117(2):542\u201350.<\/p>\n Article<\/a>\u00a0 Veit T, Barnikel M, Crispin A, Kneidinger N, Ceelen F, Arnold P, et al. Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study. Respir Res. 2020;21(1):270.<\/p>\n Article<\/a>\u00a0 Anand R, McLeese R, Busby J, Stewart J, Clarke M, Man WD, et al. Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis. Eur Respir Rev. 2023. https:\/\/doi.org\/10.1183\/16000617.0248-2022<\/a>.<\/p>\n Article<\/a>\u00a0 Edwards C, Costello E, Cassidy N, Vick B, Russell AM. Use of the patientmpower app with home-based spirometry to monitor the symptoms and impact of fibrotic lung conditions: longitudinal observational study. JMIR Mhealth Uhealth. 2020;8(11):e16158.<\/p>\n Article<\/a>\u00a0 Moor CC, van Leuven SI, Wijsenbeek MS, Vonk MC. Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study. Rheumatology (Oxford). 2021;60(5):2467\u201371.<\/p>\n Article<\/a>\u00a0 Barth S, Edwards C, Saini G, Haider Y, Williams NP, Storrar W, et al. Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study. Respiratory Research. 2024;25(162).<\/p>\n Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR. Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.02406-2016<\/a>.<\/p>\n Article<\/a>\u00a0 Nakshbandi G, Moor CC, Magri T, Veltkamp M, Nijman SFM, Overbeek MJ, et al. Online home spirometry in national pulmonary fibrosis care: insights from daily practice. ERJ Open Res. 2025(In press).<\/p>\n Velauthapillai A, Schepers GMM, Vonk MC, van den Ende CHM. Experiences of systemic sclerosis patients with home monitoring of their pulmonary function: a qualitative study. Rheumatol Adv Pract. 2024;8(2):rkae036.<\/p>\n Article<\/a>\u00a0 Akdogan A, Kilic L, Dogan I, Karadag O, Bilgen SA, Kiraz S, et al. Effect of capillaroscopic patterns on the pulse oximetry measurements in systemic sclerosis patients. Microvasc Res. 2015;98:183\u20136.<\/p>\n Article<\/a>\u00a0 Garg R, Verma S. Pulse oximetry in scleroderma patients: concerns. Acta Anaesthesiol Scand. 2008;52(9):1303\u20134.<\/p>\n Article<\/a>\u00a0 Beldner S, Rabinovich R, Polatsch DB. Scleroderma of the hand: evaluation and treatment. J Am Acad Orthop Surg. 2020;28(16):686\u201395.<\/p>\n Article<\/a>\u00a0 Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford). 2000;39(2):122\u201332.<\/p>\n Article<\/a>\u00a0 Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094\u2013108.<\/p>\n Article<\/a>\u00a0 Nakshbandi G, Moor CC, Wijsenbeek MS. Home monitoring for patients with ILD and the COVID-19 pandemic. Lancet Respir Med. 2020;8(12):1172\u20134.<\/p>\n Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n","protected":false},"excerpt":{"rendered":"Grutters JC, van den Borsch JMM. Connective Tissue Disorders. Clinical Respiratory Medicine. Third ed2008. p. 713\u201327. Fathi M,…\n","protected":false},"author":2,"featured_media":150107,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[85118,85117,85115,103,85116,61,40288,1704,60,85114,85119,41122,85120,85112,85113],"class_list":["post-150106","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-acceptability","tag-adherence","tag-connective-tissue-disease-associated-interstitial-lung-disease","tag-health","tag-idiopathic-pulmonary-fibrosis","tag-ie","tag-intensive-critical-care-medicine","tag-internal-medicine","tag-ireland","tag-oximetry","tag-patient-survey","tag-pneumology-respiratory-system","tag-raynauds-phenomenon","tag-remote-monitoring","tag-spirometry"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/150106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=150106"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/150106\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/150107"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=150106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=150106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=150106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}